Amarin (AMRN)
(Delayed Data from NSDQ)
$0.78 USD
0.00 (-0.11%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $0.78 0.00 (-0.56%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Amarin Corporation PLC [AMRN]
Reports for Purchase
Showing records 341 - 360 ( 361 total )
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
LIFE SCIENCES -The Week Ahead in Life Sciences - Upcoming Events for the Week of September 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 14
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 7
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Mid day call
Provider: WEDBUSH SECURITIES INC.
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Reports Incremental Progress Towards AMR101 NDA Submission; On Track for Q3:11 Filing
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Valuation Update Following ANCHOR Results; Raising FV to $18 from $12
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Expect Meaningful Upside Upon ANCHOR Success; Raising Fair Value to $12 from $9
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Prices Secondary Offering of up to $100 million; Lowering FV to $9 from $10 on Dilution
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
2011 Life Sciences and Healthcare Preview: Macro and Sector Trends; Catalysts; Top Picks.
Provider: WEDBUSH SECURITIES INC.
Analyst: NALBONE P
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Expect Positive ANCHOR Data in Early Q2:11, Followed By Potential Takeout; Raising Fair Value to $10 from $7
Provider: WEDBUSH SECURITIES INC.
Analyst: NASH D
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
Company: Amarin Corporation PLC
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.